SPAGO Stock Overview
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden.
+ 2 more risks
Spago Nanomedical AB (publ) Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||kr0.85|
|52 Week High||kr6.97|
|52 Week Low||kr0.74|
|1 Month Change||-9.57%|
|3 Month Change||-28.27%|
|1 Year Change||-86.74%|
|3 Year Change||-91.91%|
|5 Year Change||-90.86%|
|Change since IPO||-93.93%|
Recent News & Updates
|SPAGO||SE Biotechs||SE Market|
Return vs Industry: SPAGO underperformed the Swedish Biotechs industry which returned -29.8% over the past year.
Return vs Market: SPAGO underperformed the Swedish Market which returned -26.1% over the past year.
|SPAGO Average Weekly Movement||6.3%|
|Biotechs Industry Average Movement||8.5%|
|Market Average Movement||7.0%|
|10% most volatile stocks in SE Market||11.5%|
|10% least volatile stocks in SE Market||4.3%|
Stable Share Price: SPAGO is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SPAGO's weekly volatility (6%) has been stable over the past year.
About the Company
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014.
Spago Nanomedical AB (publ) Fundamentals Summary
|SPAGO fundamental statistics|
Is SPAGO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SPAGO income statement (TTM)|
|Cost of Revenue||kr22.54m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 08, 2022
|Earnings per share (EPS)||-0.45|
|Net Profit Margin||-677.52%|
How did SPAGO perform over the long term?See historical performance and comparison